059853281 | PUO | 34790858 | | 4691794 | 5/30/2006 12:00:00 AM | NPH | | DIS | Admission Date: 5/28/2006 Report Status: Discharge Date: 3/18/2006 ****** FINAL DISCHARGE ORDERS ****** KLUEMPER , VELVET 191-37-89-0 Portomi Spo Son Service: NSU DISCHARGE PATIENT ON: 5/28/06 AT 09:00 AM CONTINGENT UPON HO evaluation WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: KWASNICKI , HUI KATHI , M.D. , PH.D. DISPOSITION: Home DISCHARGE MEDICATIONS: FOSAMAX ( ALENDRONATE ) 70 MG PO QWEEK Starting ON 10/3 ( 11/12 ) Instructions: Give tablet on an empty stomach with a full glass of water , then wait 30 minutes before the patient eats or lies down ( to promote absorption and avoid distress ). 
Food/Drug Interaction Instruction Give on an empty stomach ( give 1hr before or 2hr after food ) Take with 8 oz of plain water Number of Doses Required ( approximate ): 3 CALCIUM CARBONATE 1 , 500 MG ( 600 MG ELEM CA )/ VIT D 200 IU 1 TAB PO DAILY COLACE ( DOCUSATE SODIUM ) 100 MG PO BID HYDROCHLOROTHIAZIDE 25 MG PO DAILY HOLD IF: SBP &lt;100 or HR &lt;50 ZESTRIL ( LISINOPRIL ) 40 MG PO DAILY HOLD IF: SBP &lt; 100 Instructions: Not recent home meds Override Notice: Override added on 5/28/06 by AMIRAULT , ERVIN A. , M.D. on order for KCL IMMEDIATE RELEASE PO ( ref # 541690390 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: needed Previous override information: Override added on 8/27/06 by FANIEL , GAYLENE , M.D. , PH.D. on order for POTASSIUM CHLORIDE IMMED. 
REL. 
PO ( ref # 003405876 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: . 
Previous override information: Override added on 8/27/06 by FANIEL , GAYLENE , M.D. , PH.D. on order for POTASSIUM CHLORIDE SLOW REL. 
PO ( ref # 704188600 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: . 
Previous override information: Override added on 8/27/06 by FANIEL , GAYLENE , M.D. , PH.D. on order for POTASSIUM CHLORIDE SLOW REL. 
PO ( ref # 707998110 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: . 
Previous override information: Override added on 8/27/06 by AMIRAULT , ERVIN A. , M.D. on order for KCL IMMEDIATE RELEASE PO ( ref # 700257609 ) POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE POTENTIALLY SERIOUS INTERACTION: LISINOPRIL &amp; POTASSIUM CHLORIDE Reason for override: needed LOSARTAN 100 MG PO DAILY HOLD IF: SBP &lt;100 or HR&lt;50 Override Notice: Override added on 5/28/06 by AMIRAULT , ERVIN A. , M.D. on order for KCL IMMEDIATE RELEASE PO ( ref # 541690390 ) POTENTIALLY SERIOUS INTERACTION: LOSARTAN POTASSIUM &amp; POTASSIUM CHLORIDE Reason for override: needed Previous override information: Override added on 8/27/06 by FANIEL , GAYLENE , M.D. , PH.D. on order for POTASSIUM CHLORIDE IMMED. 
REL. 
PO ( ref # 003405876 ) POTENTIALLY SERIOUS INTERACTION: LOSARTAN POTASSIUM &amp; POTASSIUM CHLORIDE Reason for override: . 
Previous override information: Override added on 8/27/06 by FANIEL , GAYLENE , M.D. , PH.D. on order for POTASSIUM CHLORIDE SLOW REL. 
PO ( ref # 704188600 ) POTENTIALLY SERIOUS INTERACTION: LOSARTAN POTASSIUM &amp; POTASSIUM CHLORIDE Reason for override: . 
Previous override information: Override added on 8/27/06 by FANIEL , GAYLENE , M.D. , PH.D. on order for POTASSIUM CHLORIDE SLOW REL. 
PO ( ref # 707998110 ) POTENTIALLY SERIOUS INTERACTION: LOSARTAN POTASSIUM &amp; POTASSIUM CHLORIDE Reason for override: . 
Previous override information: Override added on 8/27/06 by AMIRAULT , ERVIN A. , M.D. on order for KCL IMMEDIATE RELEASE PO ( ref # 700257609 ) POTENTIALLY SERIOUS INTERACTION: LOSARTAN POTASSIUM &amp; POTASSIUM CHLORIDE Reason for override: needed Number of Doses Required ( approximate ): 7 METFORMIN 500 MG PO BID METOPROLOL TARTRATE 150 MG PO DAILY Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
Override Notice: Override added on 11/9/06 by LIPSETT , TREVA , P.A. on order for LIDOCAINE HCL 2% SC ( ref # 192666479 ) POTENTIALLY SERIOUS INTERACTION: METOPROLOL TARTRATE &amp; LIDOCAINE HCL , LOCAL-INJ Reason for override: OXYCODONE 5 MG PO Q4H PRN Pain SIMVASTATIN 40 MG PO BEDTIME Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
Alert overridden: Override added on 4/24/06 by SWEATT , KAYLEE GAYE , M.D. POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &amp; SIMVASTATIN Reason for override: Will Follow SALT TABLET ( SODIUM CHLORIDE ) 4 GM PO TID MULTIVITAMIN THERAPEUTIC ( THERAPEUTIC MULTIVI... ) 1 TAB PO DAILY Override Notice: Override added on 4/24/06 by SWEATT , KAYLEE GAYE , M.D. on order for SIMVASTATIN PO ( ref # 636621966 ) POTENTIALLY SERIOUS INTERACTION: NIACIN , VIT. B-3 &amp; SIMVASTATIN Reason for override: Will Follow DIET: No Restrictions ACTIVITY: Resume regular exercise FOLLOW UP APPOINTMENT( S ): call 476-448-2351 for follow up with dr. oey , 1-2 weeks , ALLERGY: NKA ADMIT DIAGNOSIS: NPH PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) NPH OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay HTN DM OPERATIONS AND PROCEDURES: none OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) lumbar drain 2/21/06 BRIEF RESUME OF HOSPITAL COURSE: HPI: 75 yo F with hx/o of urinary incontince , memory loss , and difficulty walking who presents for a lumbar drain. 
Pt was involved in an MVA in 6/8 after which she had difficulty walking. 
Over the last year she had had a syndrome of progressive memory deficits , gait difficulty , and urinary incontinence. 
Head CT was performed which demonstrated ventriculomegaly. 
Lumbar puncture was done here at the Kernan To Dautedi University Of Of where thee opening pressure was 23 and 20 cc were drained. 
Following the LP there was very clear but short lived improvement in her symptoms. 
PMH: HTN , DM , arthritis , peripheral edema , hyperlipidemia , no history of cancer or heart disease PSH: Bilateral cataracts Medications: NPH 2 Units qAM , NPH 60 Units qAM , Metoprolol 100 mg qd , Metformin 500 mg BID , Fosamax 70 mg qwk , Calcium 600 mg qd , MVI , Losartan 100 mg qd , HCTZ 25 mg qd , Simvastatin 40 mg qd. 
Allergies: NKDA SHX: Speaks Hindi , family is very helpful and cooperative - they translate for patient. 
Retired teacher of fashion , Married with 8 kids , No smoking or ETOH PE: 97.5 74 180/90 18 100%RA HEENT: Neck supple , NAD CV: rrr , nl S1/S2 , no 2/6 systolic murmur Resp: LCTAB , no adventitious sounds Abd: Soft , NT , ND , +BS x4 Neuro: Awake , A+Ox3 with fluent speech , following commands appropriately. 
PERRL , EOMI , FS , TM. No pronator drift was noted on examination. 
The pt is moving all extremities well with 4/5 strength x4. 
Sensation to light touch is grossly intact throughout. 
Pt's gait is unsteady and wide based. 
Pt was able to remember only 2/3 objects after 5 minute delay. 
HOSPITAL COURSE:This pt was admitted to the hospital in the evening on 2/14 through direct admit. 
Her labs revealed low sodium. 
She was started on salt tabs and her sodium was monitored closely. 
After other labs were reviewed and antibiotics were hung , the lumbar drain was inserted at the bedside. 
The pt tolerated the procedure well. 
She was evaluated by PT and the drain was opened to drain approximately 10cc/day. 
She was evalated daily by PT and the neurosurgery team. 
ADDITIONAL COMMENTS: Please do not drive while taking pain meds. 
Sutures will be removed upon follow up in the clinic in 7-14 days. 
If fever&gt;101.5 , new weakness , new numbness , vomiting , increasing headache , wound redness/discharge , then please call office. 
DISCHARGE CONDITION: Stable TO DO/PLAN: No dictated summary ENTERED BY: AMIRAULT , ERVIN A. , M.D. ( MT1 ) 5/28/06 @ 03 ****** END OF DISCHARGE ORDERS ******